Axim Biotechnologies Inc logo

Axim Biotechnologies Inc

$ 0.10 +0.0088 (+9.65%) 03:59 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 15.65M
Enterprise V:
$ 20.57M
Volume:
514.57K
Avg Vol (2M):
344.78K
Volume:
514.57K
Market Cap $:
15.65M
PE Ratio:
At Loss
Avg Vol (2-Month):
344.78K
Enterprise Value $:
20.57M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Axim Biotechnologies Inc is a vertically integrated research and development company focused on improving the landscape for diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, it owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells, as well as for oncological indications.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -0.83
Debt-to-Equity -1.5
Debt-to-EBITDA -0.5
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -27.88
Distress
Grey
Safe
Beneish M-Score -11.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.02
9-Day RSI 53.15
14-Day RSI 55.13
6-1 Month Momentum % -43.02
12-1 Month Momentum % -87.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.06
Quick Ratio 0.06
Cash Ratio 0.02
Days Sales Outstanding 631.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.3

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -54553.85
Net Margin % -112700
ROA % -185.41
ROIC % -80.25
ROC (Joel Greenblatt) % -6875
ROCE % -229.69

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.61
EV-to-EBITDA -1.83
EV-to-Revenue 1579.57
EV-to-FCF -7.44
Earnings Yield (Greenblatt) % -62.56

Financials

AXIM's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:AXIM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.013
EPS (TTM) ($) -0.1
Beta 1.75
Volatility % 165.98
14-Day RSI 55.13
14-Day ATR ($) 0.015434
20-Day SMA ($) 0.089483
12-1 Month Momentum % -87.19
52-Week Range ($) 0.038 - 0.5899
Shares Outstanding (Mil) 164.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Axim Biotechnologies Inc Filings

Document Form Filing Date
No Filing Data

Axim Biotechnologies Inc Analysis

Share your research

Headlines

See More
No news.